Company Ovation Science Inc. OTC Markets

OVATF

CA69016D1087

Personal Products

Market Closed - OTC Markets 18:53:17 21/04/2026 BST			5-day change	1st Jan Change
0.0350 ^USD	-27.39%		+366.67%	+18.64%

08-11	Ovation Science Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
05-25	Ovation Science Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

Business description: Ovation Science Inc.

Ovation Science Inc. is a Canada-based drug development company. The Company develops topical and transdermal cannabidiol (CBD)/ tetrahydrocannabinol (THC) and other cannabinoid products which are out-licensed and also distributed under its own brands; ARLO CBD Beauty and InVibe MD (wellness line); all powered by its patented Invisicare skin delivery technology. The Company manufactures, distributes, sells, markets, sub-licenses and promotes products formulated with Invisicare, containing cannabinoids, hemp seed oil or synthetic derivatives of cannabis. The Company has developed topical and transdermal creams and lotions made with CBD, THC and combinations thereof plus hemp seed oil. Invisicare is a patented polymer-based technology for topical and transdermal skincare products. ARLO CBD Beauty offers science-based skincare solutions. Invibe MD offers a health and wellness product line infused with hemp-derived CBD and developed using Invisicare drug delivery technology.

Sales by Activity: Ovation Science Inc.

Fiscal Period: December	2021 (CAD)	2022 (CAD)	2023 (CAD)	2024 (CAD)	2025 (CAD)
Pharmaceuticals	225K	138K	61.93K	113K	67.89K

See all business segments

Geographical breakdown of sales: Ovation Science Inc.

Fiscal Period: December	2021 (CAD)	2022 (CAD)	2023 (CAD)	2024 (CAD)	2025 (CAD)
United States	-	137K	28.19K	113K	67.88K
Canada	225K	1.21K	33.74K	-	-

See all geographic segments

Executive Committee: Ovation Science Inc.

Manager	Title	Age	Since
Doreen McMorran DFI	Director of Finance/CFO	63	29/10/2023
Terry Howlett CEO	Chief Executive Officer	77	03/10/2017

See OVATION SCIENCE INC. governance

Composition of the Board of Directors: Ovation Science Inc.

Director	Title	Age	Since
Terry Howlett BRD	Director/Board Member	77	03/10/2017
Doreen McMorran BRD	Director/Board Member	63	03/10/2017
Ian Howard BRD	Director/Board Member	86	01/02/2018
Joan Chypyha BRD	Director/Board Member	60	01/02/2018
Shane Dungey BRD	Director/Board Member	-	29/10/2023
Ronald Stern BRD	Director/Board Member	-	29/10/2023

Composition of the Board of Directors

Shareholders: Ovation Science Inc.

Name	Stocks	%	Valuation
Terry Howlett 9.934 %	3,818,750	9.934 %	95 469 $
Doreen McMorran 9.934 %	3,818,750	9.934 %	95 469 $
Ronald Stern 1.886 %	725,000	1.886 %	18 125 $
Ian Howard 0.9105 %	350,000	0.9105 %	8 750 $
Joan Chypyha 0.5203 %	200,000	0.5203 %	5 000 $

List of OVATION SCIENCE INC. shareholders

Company details: Ovation Science Inc.

Ovation Science, Inc. (Canada)

1166 Alberni Street

V6E 3Z3, Vancouver

+604 982 5700

http://www.ovationscience.com

Cosmetics & Perfumes

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
L'ORÉAL	-0.14%	-0.79%	-1.52%	-7.86%	235B
GALDERMA GROUP AG	-0.41%	+0.17%	+36.72%	-	51.24B
APR CO., LTD.	+0.63%	+5.69%	+91.61%	-	10.55B
SHISEIDO COMPANY, LIMITED	+0.88%	-1.71%	+39.38%	-44.80%	8.84B
AMOREPACIFIC CORPORATION	-0.88%	-2.39%	+9.71%	+3.14%	5.87B
ELF BEAUTY	-0.62%	-0.28%	-25.11%	-30.51%	5.43B
INTERPARFUMS, INC.	-2.20%	-2.96%	-2.35%	-13.97%	3.7B
PROYA COSMETICS CO.,LTD.	-0.59%	+1.09%	-29.67%	-46.19%	3.4B
INTERPARFUMS	+0.16%	-0.64%	-19.19%	-49.30%	2.5B
Average	-0.34%	-0.23%	+11.06%	-27.07%	36.33B
Weighted average by Cap.	-0.15%	-1.18%	+7.96%	-10.28%